Weiyi Peng to CRISPR-Cas Systems
This is a "connection" page, showing publications Weiyi Peng has written about CRISPR-Cas Systems.
Connection Strength
0.760
-
Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators. J Immunother Cancer. 2021 02; 9(2).
Score: 0.702
-
UBA1 inhibition sensitizes cancer cells to PARP inhibitors. Cell Rep Med. 2024 Dec 17; 5(12):101834.
Score: 0.057